Omicron: a chimera of two early SARS-CoV-2 lineages

Signal Transduct Target Ther. 2022 Mar 17;7(1):90. doi: 10.1038/s41392-022-00949-5.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antibodies, Viral
  • COVID-19* / virology
  • Cell Line
  • Humans
  • Reassortant Viruses
  • SARS-CoV-2* / genetics

Substances

  • Antibodies, Viral